from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3247c/tmk

LFCtreatmentdescriptionclass of inhibitor

0.057

Amikacinug/mL Amikacintranslation

-0.674

Cap5-10ug/mL Capreomycintranslation

-0.521

Rox10-50 ug/mL Roxithromycintranslation

0.048

SM2-5 ug/mL Streptomycintranslation

-0.498

Tet5-10 ug/mL Tetracyclinetranslation

1.209

Rif0.2-5ug/mL Rifampicintranscription

0.263

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.776

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.943

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.212

CPZ10-50 ug/mL Chlorpromazinerespiration

0.236

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.209

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.388

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.085

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.765

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.624

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.121

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.555

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.069

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.583

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.346

KCN5-20 ug/mL Potassium cyaniderespiration

0.252

NaN30.2-2 mM Sodium aziderespiration

0.585

Nigericin50 uM Nigericinrespiration

0.136

TRC10-150 ug/mL Triclosanrespiration

-0.672

TRZ10-25 ug/mL Thioridazinerespiration

1.102

Valinomycin0.5-10 uM Valinomycinrespiration

0.139

ZnSO42 mM ZnSO4respiration

2.356

menadione6-10 ug/mL Menadionerespiration

0.446

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.313

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.222

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.027

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.194

NRP_1Non-replicating persistence stage 1dosRassociated

0.088

Amp0.2mg/mL AmpicillincellWall

0.039

Cephalexin20-100 ug/mL CephalexincellWall

0.264

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.055

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.371

EMB10-20 ug/mL EthambutolcellWall

0.606

Eta12-40 ug/mL EthionamidecellWall

0.846

INH0.2-0.4 ug/mL IsoniazidcellWall

0.884

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.290

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.631

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.621

BZA0.12 mg/mL BenzamidearomaticAmides

-0.842

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.380

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.250

H2O24 mM hydrogen peroxideDNAdamaging

0.370

Levo10 ug/mL LevofloxacinDNAdamaging

-0.457

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.750

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.259

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.420

UVUV-irradiationDNAdamaging

1.717

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.078

Antimycin12.5-50 ug/mL Antimycin A?

0.305

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.318

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.429

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.436

PA8240.2-2 ug/mL PA-824?

0.349

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.548

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.399

Verapamil50 uM Verapamil?

0.529

mercaptoethanol2 mM 2-Mercaptoethanol?

0.679

methoxatin10-20 ug/mL Methoxatin?